Table 2.

Distribution of physician reasons to delay dabigatran initiation until after discharge from acute stroke care

Reasons for delay	N	%
Severity of stroke	61	22.8
Size of infarct	52	19.4
Haemorrhagic transformation	40	14.9
Intracranial haemorrhage	8	3.0
Reason not specified	27	10.1
Patient bleeding risk factors	18	6.7
Location of infarct	14	5.2
Practical considerations	14	5.2
Intervention used to treat ischaemic stroke	8	3.0
Patient stroke risk factors	6	2.2
Recommendation from specialist	6	2.2
Altered coagulation parameters	5	1.9
Other reasons	5	1.9
Patient preference	4	1.5
Total	268	100